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LETTERS
Bartonella Species 
in Raccoons and 
Feral Cats,  
Georgia, USA
To the Editor: Bartonella spp. 
are vector-borne, facultative, intracel-
lular bacteria that infect mammalian 
erythrocytes and endothelial cells and 
might cause chronic bacteremia and 
asymptomatic infections in reservoir 
hosts (1). There are currently 30–40 
identified Bartonella species (2), and 
14 of them are zoonotic; they have a 
wide variety of reservoirs, including 
rodents, carnivores, and ungulates 
(3). This study describes 2 Bartonella 
species in an urban population of rac-
coons and compares these findings to 
Bartonella infection in sympatric feral 
cats (Felis catus).
Raccoons (Procyon lotor) (n = 
37) were live-trapped (Tomahawk 
Life Trap Company, Tomahawk, 
WI, USA) in spring and summer of 
2012 on St. Simons Island, an urban-
ized coastal barrier island in Geor-
gia in the southeastern United States 
(31°9′40″N, 81°23′13″W). The is-
land is characterized by beach, salt 
marsh, forest, freshwater slough, and 
extensive residential developments. 
Raccoons were anesthetized with 20 
mg/kg ketamine (Aveco Co., Fort 
Dodge, IA, USA) and 4 mg/kg xy-
lazine (Mobay Corp., Shawnee, KS, 
USA), and blood was collected from 
the jugular vein into tubes containing 
EDTA. Feral cat blood samples (n = 
37) from trap-neuter programs were 
collected by local veterinarians on St. 
Simons Island. Institutional Animal 
Care and Use Committee (A2011 03-
042-Y2-A2) and Georgia Department 
of Natural Resources wildlife permits 
(29-WBH-12-100) were obtained be-
fore sampling.
DNA was extracted from blood 
by using a commercial DNA extrac-
tion kit (Quick-gDNA MiniPrep; 
Zymo Research Corp., Orange, CA, 
USA). Extracted DNA was used to 
amplify the 16S–23S rRNA inter-
genic spacer region of Bartonella 
spp. by nested PCR. For outer PCR, 
we used primers QHVE-1 (5′-TTCA-
G AT G AT G AT C C C A A G C - 3 ′ ) 
and QHVE-3 (5′-AACATGTCT-
GAATATATCTTC-3′) (4,5). PCR 
was performed with an initial incuba-
tion for 2 min at 94°C; 35 cycles of 
denaturation at 94°C for 30 s, primer 
annealing at 52°C for 30 s, and elon-
gation at 72°C for 60 s; and a final in-
cubation at 72°C for 6 min.
Nested PCR was performed by 
using primers QHVE-12 (5′-CCG 
GAG GGC TTG TAG CTC AG-3′) 
and QHVE-14b (5′-CCT CACAAT 
TTC AAT AGA AC-3′) (4). Nested 
PCR conditions were identical to those 
for the outer PCR, except for the an-
nealing temperature, which was 55°C. 
Positive amplicons were separated by 
electrophoresis on a 1.2% agarose gel 
and purified by using the QIAquick 
PCR Purification Kit (QIAGEN, Va-
lencia, CA, USA).
Purified DNA amplicons (400–
600 bp) were sequenced by using an 
ABI automated sequencer (Applied 
Biosystems, Foster City, CA, USA). 
Intergenic spacer sequences from rac-
coon isolates were aligned with re-
ported Bartonella species sequences 
in GenBank by using the ClustalW al-
gorithm (6). A phylogenetic tree of the 
sequences was constructed by using 
neighbor-joining methods and maxi-
mum composite likelihood distances. 
Data were resampled 1,000 times to 
generate bootstrap values by using 
MEGA5 (7).
Of 74 samples analyzed (37 rac-
coon, 37 feral cat), 16 (43%) rac-
coon samples and 18 (48%) feral 
cat samples were positive for Bar-
tonella spp. by PCR. Thirteen posi-
tive raccoon samples and 16 positive 
feral cat samples were sequenced. 
Twelve positive raccoon samples 
and 13 positive feral cat samples 
contained Bartonella henselae. B. 
koehlerae was amplified from 1 fe-
ral cat sample and 1 raccoon sample 
(99% sequence homology with a B. 
koehlerae sequence, GenBank acces-
sion no. AF312490). Two feral cat 
samples were identified as containing 
B. clarridgeiae and showed 98% and 
100% sequence homology with a B. 
clarridgeiae sequence (GenBank ac-
cession no. AF167989) (Table; Fig-
ure, Appendix, wwwnc.cdc.gov/EID/
article/19/7/13-0010-F1.htm).
This study identified B. henselae 
and B. koehlerae in feral cat and rac-
coons and B. clarridgeiae in feral cats. 
Our results are useful because rac-
coons are potential reservoir hosts of 
zoonotic B. henselae and B. koehler-
ae, in addition to B. rochalimae, and 
there could be cross-species transmis-
sion of Bartonella spp. between feral 
cats and raccoons.
Among reservoir hosts for Bar-
tonella species, rodents and cats have 
been the most extensively studied. Ro-
dents harbor 11 Bartonella species (3). 
Cats are the principal reservoirs of B. 
clarridgeiae, which causes endocardi-
tis in humans, and B. henselae, which 
causes cat-scratch disease. However, 
little is known about Bartonella spp. 
infections in raccoons; there is only 1 
report of B. rochalimae in raccoons in 
California (8).
In this study, a relatively high pro-
portion of raccoons were infected with 
B. henselae, implying that there is spill-
over of B. henselae from feral cats to 
raccoons or that raccoons are another 
active reservoir for B. henselae. B. 





Bartonella species Raccoon (Procyon lotor) Feral	cat	(Felis catus) 
B. henselae 12/37 13/37 
B. koehlerae 1/37 1/37 




zoonotic; cats are primary reservoirs, 
and humans and dogs are accidental 
hosts (1). However, B. clarridgeiae 
was recently detected in rodent fleas 
in China (9) and B. koehlerae was iso-
lated from feral pigs from the south-
eastern United States (10), suggesting 
that these pathogens also have multiple 
reservoir species.
Clarifying whether Bartonella 
infections in raccoons are caused 
by spillover from feral cats needs 
further study. Additional samples 
from raccoons and other species in 
urbanized and undeveloped habitats 
with different host species compo-
sition (e.g., cat-free environment) 
might enable further Bartonella spp. 
characterization in wildlife. We sus-
pect urban raccoons and feral cats 
play a major role in Bartonella spp. 
transmission.
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Disease in  
HIV-Infected Infant, 
Vietnam
To the Editor: Guidelines for the 
diagnosis and management of Myco-
bacterium bovis BCG disease in HIV-
infected children are lacking. BCG 
strains are intrinsically resistant to 
pyrazinamide and in some cases have 
low-level resistance to isoniazid (6). 
However, data on acquired drug resis-
tance in M. bovis BCG are limited. We 
describe a case of BCG disease caused 
by a rifampin-resistant strain of M. 
bovis BCG in an HIV-infected infant 
in Vietnam.
The daughter of a known HIV-
infected woman, who did not fully 
adhere to antiretroviral therapy (ART) 
during pregnancy, received the M. bo-
vis intradermal BCG (Pasteur strain) 
vaccine at birth. HIV infection was 
diagnosed in the infant by PCR when 
she was 8 weeks of age. At 9 months 
of age, she was admitted to the Pedi-
atric Infectious Diseases Department 
of the Pham Ngoc Thach Hospital (Ho 
Chi Minh City, Vietnam) because of a 
voluminous ipsilateral axillary mass 
at the site of the vaccination, fever, 
weight loss, and hepatosplenomegaly. 
The percentage of CD4+ T cells was 
27% (1,620 cells/mm3). Regional BCG 
disease was clinically diagnosed with-
out microbiological investigation, and 
a broad antimycobacterial therapy tar-
geting M. tuberculosis complex species 
was started with 5 mg/kg isoniazid, 10 
mg/kg rifampin, and 25 mg/kg pyrazin-
amide. After 6 weeks of antimycobac-
terial therapy, ART was initiated with 
lamivudine, stavudine, and abacavir. 
After 6 months of antimycobac-
terial treatment, the infant was hospi-
talized again for recurrent inflamma-
tion and fistulization of the axillary 
lymph nodes associated with fever. 
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